Italy · AIFA medicine catalogue
BLINCYTO
A source-listed package record. Different packs may share the same medicine name.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 044550010
- Form
- POLVERE PER CONCENTRATO E SOLUZIONE PER SOLUZIONE PER INFUSIONE
- Composition / generic term
- BLINATUMOMAB
- Company as listed by source
- AMGEN EUROPE B.V.
- Source status
- Autorizzata
- Supply classification
- Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile
Source-listed ingredients
- BLINATUMOMAB — 38.5 microgrammi
These values do not establish equivalence or a dose recommendation.
Packages
- 38,5 MICROGRAMMI - POLVERE PER CONCENTRATO E SOLUZIONE PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - POLVERE:FLACONCINO (VETRO) 38,5MCG - SOLUZIONE: 10 ML FLACONCINO (VETRO) - 1 FLACONCINO + 1 FLACONCINO
Source and coverage
Open AIFA medicine catalogue →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Italy records →